News
TyraTech Announces first patent granted for its Extend™ Technology
04 February 2013
TyraTech Inc (AIM: TYR and TYRU), a life sciences company focusing on natural pest control and healthcare products, has received notification that its Extend™ patent has been granted in South Africa. The patent proves the proprietary nature of the Company's technology platform and protects a broad range of synergistic combinations of natural and synthetic compounds, which can be used against a variety of target pests. The patent has a 20-year term, which expires in March 2029.
Bruno Jactel, CEO, said: "These patents are important to demonstrate the synergy between our blends and synthetic compounds and that we are uniquely able to improve the efficacy while reducing the environmental footprint of synthetic pesticides. This will support both the strategy of ENVANCE Technologies, our joint venture with AMVAC Chemical Corporation and our animal health strategy."
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
+1 919 415 4310
Bruno Jactel Chief Executive Officer
+1 919 415 4340
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 7496 3000
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford /Helen Westaway (Public Relations)
Tel + 44 7933 8792
tyratech@walbrookpr.com
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.